3rd ADC Payload Summit | November 4-6, 2026 | Boston, USA

The 3rd ADC Payload Summit is the premier industry event dedicated exclusively to advancing payload innovation within the antibody-drug conjugate (ADC) landscape. Bringing together leading experts from across payload discovery, medicinal chemistry, biology, translational science, toxicology, and ADC development, the summit provides a focused platform for exploring the next generation of payload technologies and strategies that will shape the future of targeted cancer therapies.

As the ADC field continues to expand rapidly, developers are facing increasing challenges around resistance mechanisms, safety profiles, therapeutic index optimization, and clinical differentiation. This summit is designed to help attendees address these challenges by sharing the latest scientific advances, practical lessons learned, and emerging approaches that are driving payload innovation forward. Participants will gain insights into novel payload classes, dual-payload ADC strategies, molecular glues, degrader conjugates, NMT inhibitors, and other cutting-edge modalities that have the potential to overcome resistance and improve patient outcomes.

The conference agenda features presentations, panel discussions, workshops, and case studies delivered by experts from leading organizations across the ADC ecosystem. Attendees will explore topics including payload selection, linker-payload design, clinical translation, preclinical modeling, toxicity management, and the development of differentiated mechanisms of action. The event provides a unique opportunity to benchmark approaches against peers and learn directly from teams developing some of the industry’s most innovative ADC programs.

In addition to its scientific content, the 3rd ADC Payload Summit offers highly interactive networking opportunities designed to foster meaningful collaboration. Through curated matchmaking roundtables, focused discussion groups, and dedicated networking sessions, participants can connect with potential partners, exchange ideas, and identify solutions to shared development challenges.

Whether advancing established payload classes or pioneering entirely new ADC modalities, attendees will leave the summit with actionable insights, valuable industry connections, and a clearer understanding of how to accelerate the development of next-generation ADC therapeutics.

To know more visit: https://ter.li/zkq2dnln